PD-1/PD-L1 Inhibitors Plus Antiangiogenic Drugs Versus Sorafenib as the First Line Treatment for Advanced Hepatocellular Carcinoma: A Phase 3 RCTs Based Meta-Analysis.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/393D37B8.svg?ark=w1%2F20260523%2F393D37B8&value=id)](https://nobleid.org/work/w1/20260523/393D37B8)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors